V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma
- 19 March 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 211 (1) , 11-18
- https://doi.org/10.1016/j.canlet.2004.01.035
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfoldProceedings of the National Academy of Sciences, 2003
- EBNA-1 sequence variations reflect active EBV replication and disease status or quiescentlatency in lymphocytesJournal of Medical Virology, 2003
- Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4Nature Genetics, 2002
- Signature Amino Acid Changes in Latent Membrane Protein 1 Distinguish Epstein–Barr Virus StrainsVirology, 1999
- The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.Journal of General Virology, 1999
- Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells.Journal of General Virology, 1997
- The cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene family.Proceedings of the National Academy of Sciences, 1994
- EBV strain variation: Geographical distribution and relation to disease stateVirology, 1992
- Epstein–Barr virus infection and replication in a human epithelial cell systemNature, 1992
- Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinomaJournal of General Virology, 1991